Larry A Walker

US Patent:

7468445, Dec 23, 2008

Filed:

Aug 7, 2003

Appl. No.:

10/523964

Inventors:

Mitchell Avery - Oxford MS, US
Larry A. Walker - Oxford MS, US
Nakul Telang - University MS, US

Assignee:

University of Mississippi - University MS

International Classification:

C07D 311/00
A01N 43/16

US Classification:

549399, 514456

Abstract:

The present invention provides a method of preventing or treating one or more of the following medical conditions, or treating symptoms of one or more of the following medical conditions: amebic infections, giardiasis, estrogen deficient states, osteoporosis, cardiovascular heart disease, high cholesterol levels, hyperlipidemia, cancer by administering to a subject having, or predisposed to, one or more of the conditions, a therapeutically effective amount of a compound of the present invention and a pharmaceutically acceptable carrier.

US Patent:

20070190188, Aug 16, 2007

Filed:

Dec 13, 2006

Appl. No.:

11/610343

Inventors:

Larry Walker - Oxford MS, US
Babu Tekwani - Oxford MS, US
Lalit Tripathi - Lucknow, IN

Assignee:

The University of Mississippi - University MS

International Classification:

A61K 31/47
A61K 31/496
A61K 36/752

US Classification:

424736000, 514311000, 424777000, 514028000, 514254070, 514253080, 514312000

Abstract:

A method of controlling toxicity to a user caused by administration to the user of an aminoquinoline compound comprising administering to the user a toxicity controlling amount of at least one inhibitor of a cytochrome P450 (CYP) enzyme.

US Patent:

20090192152, Jul 30, 2009

Filed:

Dec 23, 2008

Appl. No.:

12/343441

Inventors:

Mitchell Avery - Oxford MS, US
Larry A. Walker - Oxford MS, US
Nakul Telang - Richmond VA, US

International Classification:

A61K 31/5377
A61K 31/352
A61K 31/497
A61K 31/445
A61K 31/40

US Classification:

5142335, 514456, 51425411, 514320, 514422

Abstract:

The present invention provides a method of preventing or treating one or more of the following medical conditions, or treating symptoms of one or more of the following medical conditions: amebic infections, giardiasis, estrogen deficient states, osteoporosis, cardiovascular heart disease, high cholesterol levels, hyperlipidemia, cancer by administering to a subject having, or predisposed to, one or more of the conditions, a therapeutically effective amount of a compound of the present invention and a pharmaceutically acceptable carrier.

US Patent:

20220361719, Nov 17, 2022

Filed:

May 17, 2021

Appl. No.:

17/321967

Inventors:

Larry D. Walker - Memphis TN, US

International Classification:

A47K 5/05

Abstract:

Push-On-Soaps is a soap that can be easily attacked by simple pushing it on a small peg. The soap is designed with a small hold at the bottom that only goes halfway through the bottom and is the same diameter as the peg it is simply pushed down firmly on the peg. Once the soap is pushed on peg, it is now locked in place once it get wet.